S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)

Anwaar Saeed, Sarah Colby, Paul Eliezer Oberstein, Dan G. Duda, Robin Park, Rajiv Agarwal, Colmar Figueroa-Moseley, Riha Vaidya, Joseph M. Unger, Katherine A. Guthrie, Flavio G. Rocha, Maheswari Senthil, Rachael A. Safyan, Zev A. Wainberg, Syma Iqbal, E. Gabriela Chiorean, Philip A. Philip

Open source

DOI: 10.6084/m9.figshare.28689396.v1
Published: 2025
Container: Not recorded
Publisher: Taylor & Francis
Open access: yes

Credibility signals

limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by/4.0/legalcode. Presence improves reuse transparency, not research validity. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.6084/m9.figshare.28689396.v1,
  title = {S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)},
  author = {Anwaar Saeed and Sarah Colby and Paul Eliezer Oberstein and Dan G. Duda and Robin Park and Rajiv Agarwal and Colmar Figueroa-Moseley and Riha Vaidya and Joseph M. Unger and Katherine A. Guthrie and Flavio G. Rocha and Maheswari Senthil and Rachael A. Safyan and Zev A. Wainberg and Syma Iqbal and E. Gabriela Chiorean and Philip A. Philip},
  year = {2025},
  doi = {10.6084/m9.figshare.28689396.v1},
  url = {https://doi.org/10.6084/m9.figshare.28689396.v1}
}

RIS

TY  - JOUR
TI  - S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)
AU  - Anwaar Saeed
AU  - Sarah Colby
AU  - Paul Eliezer Oberstein
AU  - Dan G. Duda
AU  - Robin Park
AU  - Rajiv Agarwal
AU  - Colmar Figueroa-Moseley
AU  - Riha Vaidya
AU  - Joseph M. Unger
AU  - Katherine A. Guthrie
AU  - Flavio G. Rocha
AU  - Maheswari Senthil
AU  - Rachael A. Safyan
AU  - Zev A. Wainberg
AU  - Syma Iqbal
AU  - E. Gabriela Chiorean
AU  - Philip A. Philip
PY  - 2025
DO  - 10.6084/m9.figshare.28689396.v1
UR  - https://doi.org/10.6084/m9.figshare.28689396.v1
ER  -

APA

Saeed, A., Colby, S., Oberstein, P. E., Duda, D. G., Park, R., Agarwal, R., Figueroa-Moseley, C., Vaidya, R., Unger, J. M., Guthrie, K. A., Rocha, F. G., Senthil, M., Safyan, R. A., Wainberg, Z. A., Iqbal, S., Chiorean, E. G., & Philip, P. A. (2025). S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE). https://doi.org/10.6084/m9.figshare.28689396.v1

Source records

datacite · retrieved 2026-11-10T13:50:20.931Z